Clinical Trials Logo
  1. Home
  2. Chronic Kidney Disease Stage 3
  3. NCT01709994

Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients

Chronic Kidney Disease Stage 3 Clinical Trial

Official title:
Effect of Aspirin in Primary Prevention of Cardiovascular Risk in Patients With Chronic Kidney Disease (AASER Study)

Clinical Trial Summary

The objective of the study is to examine whether the use of low-dose aspirin (75-100 mg / day) reduces the risk of cardiovascular disease in patients with chronic kidney disease (stage 3 or 4).

Clinical Trial Description

Hypothesis: The low-dose aspirin reduces cardiovascular risk in patients with chronic kidney disease without increasing the risk of bleeding ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01709994
Study type Interventional
Source Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales
Contact JOSE LUÑO, MD, PHD
Phone 0034915868319
Email jluno.hgugm@salud.madrid.org
Status Recruiting
Phase Phase 3
Start date May 2010
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05169411 - Preserving Kidney Function in Children With Chronic Kidney Disease N/A
Terminated NCT03529071 - Empowering Veterans to Communicate With Healthcare Providers N/A
Recruiting NCT03311321 - Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients N/A
Active, not recruiting NCT05198284 - Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
Recruiting NCT05797506 - Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease Phase 2
Active, not recruiting NCT05225454 - The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
Completed NCT01748396 - Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol Phase 4
Completed NCT04012957 - Desidustat in the Treatment of Anemia in CKD Phase 3
Completed NCT03242252 - Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control Phase 3
Recruiting NCT01509716 - Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients N/A